Jed Dorsheimer's questions to Oklo Inc (OKLO) leadership • Q2 2025
Question
Jed Dorsheimer of William Blair inquired about the pipeline's mix between behind-the-meter and front-of-the-meter opportunities and asked which specific radioisotopes Oklo has a competitive advantage in producing for the radiopharma market.
Answer
Co-Founder, CEO & Director Jacob Dewitte stated that while behind-the-meter applications are compelling, near-term deployments may favor grid-tied or hybrid solutions. For radioisotopes, he explained that the strategy includes extracting isotopes like strontium-90 from recycled fuel and using Atomic Alchemy's cost-effective reactor design to produce known isotopes more cheaply, aiming to create an ecosystem of isotopic abundance.